Headlands Technologies’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$358K Sell
17,453
-4,896
-22% -$83K 0.04% 500
2026
Q1
$355K Buy
22,349
+10,303
+86% +$224K 0.04% 453
2025
Q4
$316K Buy
12,046
+2,553
+27% +$66.2K 0.03% 505
2025
Q3
$215K Sell
9,493
-5,157
-35% -$106K 0.02% 528
2025
Q2
$291K Buy
14,650
+7,609
+108% +$148K 0.03% 403
2025
Q1
$119K Buy
7,041
+524
+8% +$8.93K 0.01% 554
2024
Q4
$120K Buy
+6,517
New +$127K 0.01% 631
2024
Q3
– Sell
-50
Closed -$981 – 1302
2024
Q2
$981 Buy
+50
New +$1.04K ﹤0.01% 1066
2024
Q1
– Sell
-60
Closed -$1.74K – 1338
2023
Q4
$1.74K Sell
60
-347
-85% -$9.29K ﹤0.01% 882
2023
Q3
$10.9K Sell
407
-1,533
-79% -$52.3K 0.01% 683
2023
Q2
$71.8K Buy
+1,940
New +$67.6K 0.02% 424

Other funds holding FLGT

Headlands Technologies's FLGT Position: Q2 2026 in Review

Headlands Technologies reduced its Fulgent Genetics (FLGT) stake by 22% in Q2 2026, selling an estimated $83K and leaving 17,453 shares worth $358K. The position accounts for 0.04% of the portfolio, ranked #500.

Headlands Technologies first reported a position in FLGT in Q2 2023 and has held it in 11 quarters since. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Headlands Technologies held 17,453 shares of Fulgent Genetics worth $358K as of Q2 2026.
  • Headlands Technologies sold 4,896 Fulgent Genetics shares in Q2 2026, an estimated $83K.
  • Fulgent Genetics made up 0.04% of Headlands Technologies's portfolio in Q2 2026, its #500 holding.
  • Headlands Technologies first reported a position in Fulgent Genetics in Q2 2023 and has held it in 11 quarters since.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.